11:10 AM EST, 12/16/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts started the week off higher late Monday morning, rising 0.32% to 1,343.34 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and Grifols ( GRFS ) , which rose 4.3% and 3.9% respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Ascendis Pharma ( ASND ) , which increased 3.1% and 2.7% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which fell 18% and 3.1% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and petroleum refiner Equinor ( EQNR ) , which were down 2.8% and 2.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 8.6% and 5% respectively. They were followed by biopharmaceutical companies Verona Pharma ( VRNA ) and Amarin ( AMRN ) , which were up 4.6% and 2.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Trinity Biotech ( TRIB ) , which dropped 3.7% and 2.2% respectively. They were followed by oil and gas company BP (BP) and insurance company Prudential (PUK), which lost 2.1% and 1.1% respectively.